Literature DB >> 21083064

'False-positive' and 'false-negative' test results in clinical urine drug testing.

Gary M Reisfield1, Bruce A Goldberger, Roger L Bertholf.   

Abstract

The terms 'false-positive' and 'false-negative' are widely used in discussions of urine drug test (UDT) results. These terms are inadequate because they are used in different ways by physicians and laboratory professionals and they are too narrow to encompass the larger universe of potentially misleading, inappropriate and unexpected drug test results. This larger universe, while not solely comprised of technically 'true' or 'false' positive or negative test results, presents comparable interpretive challenges with corresponding clinical implications. In this review, we propose the terms 'potentially inappropriate' positive or negative test results in reference to UDT results that are ambiguous or unexpected and subject to misinterpretation. Causes of potentially inappropriate positive UDT results include in vivo metabolic conversions of a drug, exposure to nonillicit sources of a drug and laboratory error. Causes of potentially inappropriate negative UDT results include limited assay specificity, absence of drug in the urine, presence of drug in the urine, but below established assay cutoff, specimen manipulation and laboratory error. Clinical UDT interpretation is a complicated task requiring knowledge of recent prescription, over-the-counter and herbal drug administration, drug metabolism and analytical sensitivities and specificities.

Mesh:

Substances:

Year:  2009        PMID: 21083064     DOI: 10.4155/bio.09.81

Source DB:  PubMed          Journal:  Bioanalysis        ISSN: 1757-6180            Impact factor:   2.681


  6 in total

1.  Competitive volumetric bar-chart chip with real-time internal control for point-of-care diagnostics.

Authors:  Ying Li; Jie Xuan; Tom Xia; Xin Han; Yujun Song; Zheng Cao; Xin Jiang; Yi Guo; Ping Wang; Lidong Qin
Journal:  Anal Chem       Date:  2015-03-18       Impact factor: 6.986

2.  Assessment concordance and predictive validity of self-report and biological assay of cocaine use in treatment trials.

Authors:  Suzanne E Decker; Tami Frankforter; Theresa Babuscio; Charla Nich; Samuel A Ball; Kathleen M Carroll
Journal:  Am J Addict       Date:  2014-03-15

Review 3.  Opioids in Hemodialysis Patients.

Authors:  Sahir Kalim; Karen S Lyons; Sagar U Nigwekar
Journal:  Semin Nephrol       Date:  2021-01       Impact factor: 5.299

4.  Maintenance treatment for opioid dependence with slow-release oral morphine: a randomized cross-over, non-inferiority study versus methadone.

Authors:  Thilo Beck; Christian Haasen; Uwe Verthein; Stephan Walcher; Christoph Schuler; Markus Backmund; Christian Ruckes; Jens Reimer
Journal:  Addiction       Date:  2014-01-19       Impact factor: 6.526

5.  Counselors' Clinical Use of Definitive Drug Testing Results in Their Work with Substance-Use Clients: a Qualitative Study.

Authors:  Adam Rzetelny; Barbara Zeller; Nicholas Miller; Kathy Egan City; Kenneth L Kirsh; Steven D Passik
Journal:  Int J Ment Health Addict       Date:  2015-07-21       Impact factor: 3.836

6.  Urine drug screens: Considerations for the psychiatric pharmacist.

Authors:  G Lucy Wilkening; Genevieve M Hale; Clint Ross
Journal:  Ment Health Clin       Date:  2016-03-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.